Pharmacologic and Genetic Investigation of PI3K p110delta in Chronic Lymphocytic Leukemia

Pharmacologic and Genetic Investigation of PI3K p110delta in Chronic Lymphocytic Leukemia

Bibliographic Details
Main Author:	Dong, Shuai
Language:	English
Published:	The Ohio State University / OhioLINK 2017
Subjects:	Biomedical Research Pharmaceuticals Immunology Chronic lymphocytic leukemia PI3K p110delta
Online Access:	http://rave.ohiolink.edu/etdc/view?acc_num=osu1503066319794882

Similar Items

Lights and Shade of Next-Generation Pi3k Inhibitors in Chronic Lymphocytic Leukemia
by: Visentin A, et al.
Published: (2020-09-01)

Lessons, Challenges and Future Therapeutic Opportunities for PI3K Inhibition in CLL
by: Valerio Guarente, et al.
Published: (2021-03-01)

Phosphoinositide 3-Kinase Signaling in the Tumor Microenvironment: What Do We Need to Consider When Treating Chronic Lymphocytic Leukemia With PI3K Inhibitors?
by: Ebru Aydin, et al.
Published: (2021-01-01)

Idelalisib therapy of indolent B-cell malignancies: chronic lymphocytic leukemia and small lymphocytic or follicular lymphomas
by: Madanat YF, et al.
Published: (2016-03-01)

Involvement of memory T-cells in the pathophysiology of chronic lymphocytic leukemia
by: Rodolfo Patussi Correia, et al.
Published: (2014-01-01)

Overview of recent developments in chronic lymphocytic leukemia
by: Preetesh Jain, et al.
Published: (2012-01-01)

PI3K in juvenile myelomonocytic leukemia
by: Goodwin, Charles B.
Published: (2013)

Deficiency of PI3-Kinase catalytic isoforms p110γ and p110δ in mice enhances the IL-17/G-CSF axis and induces neutrophilia
by: Kirsten Bucher, et al.
Published: (2017-07-01)

Is There a Role for Dual PI3K/mTOR Inhibitors for Patients Affected with Lymphoma?
by: Chiara Tarantelli, et al.
Published: (2020-02-01)

The PI-3-Kinase P110α Catalytic Subunit of T Lymphocytes Modulates Collagen-Induced Arthritis
by: María Montes-Casado, et al.
Published: (2021-06-01)

Immunological Synapse in the Biology of Chronic Lymphocytic Leukemia
by: DS Badmazhapova, et al.
Published: (2018-10-01)

p110d PI3 kinase pathway: emerging roles in cancer
by: Niki eTzenaki, et al.
Published: (2013-03-01)

Functional characterization and multi-factor analysis of exhaustion in chronic lymphocytic leukemia T cells
by: Lee, Joanne Haeun
Published: (2021)

Biclonal chronic lymphocytic leukemia: A study of two cases and review of literature
by: Kiran Ashok Ghodke, et al.
Published: (2017-01-01)

Consistent B Cell Receptor Immunoglobulin Features Between Siblings in Familial Chronic Lymphocytic Leukemia
by: P. Martijn Kolijn, et al.
Published: (2021-08-01)

The PI3K∂-Selective Inhibitor Idelalisib Induces T- and NK-Cell Dysfunction Independently of B-Cell Malignancy-Associated Immunosuppression
by: Lisa Rohrbacher, et al.
Published: (2021-03-01)

PI3Kinase-p110δ Overexpression Impairs Dendritic Morphogenesis and Increases Dendritic Spine Density
by: Veronica L. Hood, et al.
Published: (2020-02-01)

Inhibition of PI3K Isoform p110γ Increases both Anti-Tumor and Immunosuppressive Responses to Aggressive Murine Head and Neck Squamous Cell Carcinoma with Low Immunogenicity
by: Kelvin Anderson, et al.
Published: (2021-02-01)

THE USE OF MONOCLONAL ANTIBODIES IN THE TREATMENT OF AUTOIMMUNE COMPLICATIONS OF CHRONIC LYMPHOCYTIC LEUKEMIA
by: Luca Laurenti
Published: (2013-04-01)

Evaluation of Hypogammaglobulinemia in Chronic Lymphocytic Leukemia Patients and Its Relation to Poor Prognostic Factors
by: Mesut Ayer, et al.
Published: (2018-09-01)

Pharmacological Targeting of Phosphoinositide Lipid Kinases and Phosphatases in the Immune System: Success, Disappointment and New Opportunities
by: Stephen Geoffrey Ward, et al.
Published: (2012-08-01)

Appearance and Disappearance of Chronic Myeloid Leukemia (CML) in Patient with Chronic Lymphocytic Leukemia (CLL)
by: Mehrdad Payandeh, et al.
Published: (2014-12-01)

Structural Determinants of Isoform Selectivity in PI3K Inhibitors
by: Michelle S. Miller, et al.
Published: (2019-02-01)

VENETOCLAX IN TREATMENT OF CHRONIC LYMPHOCYTIC LEUKEMIA (literature review)
by: T. E. Byalik
Published: (2018-07-01)

Monoclonal Antibody and Liposomal Nanoparticle-based Targeting Therapies for Chronic Lymphocytic Leukemia
by: Mao, Yicheng
Published: (2012)

Case Study: Mechanism for Increased Follicular Helper T Cell Development in Activated PI3K Delta Syndrome
by: Timothy J. Thauland, et al.
Published: (2019-04-01)

A case of double leukemia: chronic myeloid leukemia intolerant to imatinib and chronic lymphocytic leukemia
by: Miriana Rocchi
Published: (2015-10-01)

Chronic lymphocytic leukemia in general practice
by: Đurović Ljiljana P.
Published: (2021-01-01)

An unusual presentation of chronic lymphocytic leukemia
by: Dinesh Atwal, et al.
Published: (2017-07-01)

An unusual presentation of chronic lymphocytic leukemia
by: Dinesh Atwal, et al.
Published: (2017-01-01)

CRKL Mediates p110β-Dependent PI3K Signaling in PTEN-Deficient Cancer Cells
by: Jing Zhang, et al.
Published: (2017-07-01)

Simultaneous Chronic Lymphocytic Leukemia and Hairy Cell Leukemia: a Sporadic Event? A Semantic Point of View.
by: luiza akria, et al.
Published: (2014-08-01)

Serum selenium levels in chronic lymphocytic leukemia
by: Taleb Azarm, et al.
Published: (2013-01-01)

Targeting PI3K Signaling in Acute Lymphoblastic Leukemia
by: Vanessa Edna Sanchez, et al.
Published: (2019-01-01)

Phosphoinositide 3-Kinase p110 Delta Differentially Restrains and Directs Naïve Versus Effector CD8+ T Cell Transcriptional Programs
by: Laura Spinelli, et al.
Published: (2021-06-01)

B-lymphocytic infiltration of the prostate to a patient with chronic lymphocytic leukemia. A case report
by: Ioannis Anastasiou, et al.
Published: (2017-03-01)

Disorders Related to PI3Kδ Hyperactivation: Characterizing the Clinical and Immunological Features of Activated PI3-Kinase Delta Syndromes
by: Vyanka Redenbaugh, et al.
Published: (2021-08-01)

A case of Norwegian scabies in a patient with leukemia cutis secondary to chronic lymphocytic leukemia
by: Minu Mathew, et al.
Published: (2020-11-01)

T LYMPHOCYTE SUBSETS STUDIED IN A PATIENT WITH TWO ASSOCIATED HEMATOLOGIC NEOPLASIAS – CHRONIC LYMPHOCYTIC LEUKEMIA B AND CHRONIC MYELOID LEUKEMIA
by: Georgiana Ene, et al.
Published: (2019-09-01)

METABOLIC STATE OF BLOOD LYMPHOCYTES IN CHRONIC MYELOID LEUKEMIA AND CHRONIC LYMPHOID LEUKEMIA
by: O. V. Smirnova, et al.
Published: (2014-07-01)